Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog
Publication date
2016-07-07
Authors
Toom, Marjolein Lisette den
Dobak, Tetyda P.
Broens, E.M.
Valtolina, Chiara
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
BACKGROUND: In dogs with canine monocytic ehrlichiosis (CME), respiratory signs are uncommon and clinical and radiographic signs of interstitial pneumonia are poorly described. However, in human monocytic ehrlichiosis, respiratory signs are common and signs of interstitial pneumonia are well known. Pulmonary hypertension (PH) is classified based on the underlying disease and its treatment is aimed at reducing the clinical signs and, if possible, addressing the primary disease process. PH is often irreversible, but can be reversible if it is secondary to a treatable underlying etiology. CME is currently not generally recognized as one of the possible diseases leading to interstitial pneumonia and secondary PH in dogs. Only one case of PH associated with CME has been reported worldwide.
Keywords
Canine, Ehrlichiosis, Interstitial lung disease, Pulmonary hypertension, Reversible, antiparasitic agent, doxycycline, pimobendan, pyridazine derivative, sildenafil, vasodilator agent, animal, case report, complication, diagnostic imaging, dog, dog disease, ehrlichiosis, heart failure, pulmonary hypertension, interstitial lung disease, male, pathology, thorax radiography, treatment outcome, veterinary, SDG 3 - Good Health and Well-being
Citation
Toom, M L D, Dobak, T P, Broens, E M & Valtolina, C 2016, 'Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog', Acta Veterinaria Scandinavica, vol. 58, no. 1, 46. https://doi.org/10.1186/s13028-016-0228-1